A Brief, Blood-Boiling History of the Opioid Epidemic

From OxyContin coupons to fentanyl-laced heroin, this is how the crisis unfolded.

A Maryland cop counts pill capsules suspected to contain heroin.Lexey Swall/Grain Images

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

The scale of the overdose epidemic is hard to fathom. In 2016, overdoses claimed 64,000 lives—more than the US military casualties in Vietnam and Iraq combined. The origins of today’s crisis, a perfect storm of potent, easily accessible opioids, trace back to aggressive pharmaceutical marketing and liberal painkiller prescribing in the 1990s and 2000s. Here’s how it happened:

1970s: Percocet and Vicodin are introduced, but physicians are wary of prescribing them because of their addictive qualities.

1995: The American Pain Society promotes the “Pain Is the Fifth Vital Sign” standard, urging doctors to monitor pain along with pulse, breathing, blood pressure, and temperature. Purdue Pharma is one of 28 corporate donors.

The home page of Partners Against Pain, a promotional website created by Purdue Pharma in 2000

Internet Archives

1996: Purdue Pharma debuts OxyContin with the most aggressive marketing campaign in pharmaceutical history, downplaying its addictiveness. Over the next five years, the number of opioid painkiller prescriptions jumps by 44 million.

1997: Arthur Sackler, whose family owns Purdue Pharma, is posthumously inducted into the Medical Advertising Hall of Fame for “bringing the full power of advertising and promotion to pharmaceutical marketing.”

1998: Purdue distributes 15,000 copies of “I Got My Life Back,” a promotional video featuring a doctor saying opioids “do not have serious medical side effects” and “should be used much more than they are.” It also offers new patients a free first OxyContin prescription.

An OxyContin patient in Purdue Pharma’s “I Got My Life Back”

Milwaukee Journal Sentinel/YouTube

2001: The Joint Commission, a nonprofit charged with accrediting hospitals, promotes the now familiar 0-10 pain scale and begins judging hospitals based on patient satisfaction with pain treatment. The commission and Purdue team up on a guide for doctors and patients that says, “There is no evidence that addiction is a significant issue when persons are given opioids for pain control.”

2002: US doctors prescribe roughly 23 times more OxyContin than they did in 1996; sales of the drug have increased more than thirtyfold.

Purdue Pharma’s OxyContin

Pureradiancephoto/Getty

2004: With input from a Purdue exec, the Federation of State Medical Boards recommends sanctions against doctors who undertreat pain.

2007: Three drug distributors—McKesson, Cardinal Health, and AmerisourceBergen—make $17 billion by flooding West Virginia pharmacies with opioid painkillers between 2007 and 2012, according to a subsequent Pulitzer Prize-winning Charleston Gazette-Mail investigation.

2009: The Joint Commission removes the requirement to assess all patients for pain. By now, the United States is consuming the vast majority of the world’s opioid painkillers: 99 percent of all hydrocodone and 81 percent of oxycodone.

Fatal doses of heroin, fentanyl, and carfentanil

Kensington Police Service

2010: Cheap, strong Mexican heroin makes its way to American rural and suburban areas. Meanwhile, the Affordable Care Act offers addiction treatment coverage to many Americans for the first time. Annual OxyContin sales exceed $3 billion.

2011: The Centers for Disease Control and Prevention declares that painkiller overdoses have reached “epidemic levels.”

2012: Health care providers write 259 million opioid painkiller prescriptions—nearly enough for every American to have a bottle of pills. The increasingly white face of addiction changes how policymakers frame the problem, from a moral failing necessitating prison time to a disease requiring treatment.

2013: Fentanyl, a painkiller up to 50 times more powerful than heroin, starts to make its way into the heroin supply. Most of it is illicitly produced in China.

2015: Seizures of fentanyl have multiplied by fifteenfold since 2013. About 12.5 million Americans report misusing painkillers; nearly 1 million report using heroin.

Michelle Holley holds a photo of her daughter, Jaime, who overdosed in 2016.

Lynne Sladky/AP

2016: An estimated 64,000 Americans die of drug overdoses—more than all US military casualties in the Vietnam and Iraq wars combined. In December, Congress passes legislation allotting $1 billion to fund opioid addiction treatment and prevention efforts over two years.

2017: President Donald Trump declares a public health state of emergency, which opens up a fund of just $57,000. The GOP tries repeatedly to repeal Obamacare, a move that would take away addiction treatment coverage for an estimated 3 million Americans.

This article has been updated. 

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate